What is the recommended initial dose of colchicine (Colcrys) for an adult patient with acute gout and potential kidney impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colchicine Dosing for Acute Gout

For acute gout flares, administer colchicine 1.2 mg at the first sign of symptoms, followed by 0.6 mg one hour later (total 1.8 mg over one hour), then continue 0.6 mg once or twice daily until the attack resolves—but only if treatment starts within 36 hours of symptom onset. 1, 2, 3, 4

Critical Timing Requirement

  • Treatment must begin within 36 hours of symptom onset; effectiveness drops significantly beyond this window, making colchicine inappropriate for delayed presentations 1, 2, 3
  • Optimal efficacy occurs when started within 12 hours of the first symptoms 1
  • Consider a "pill in the pocket" approach for well-informed patients to self-medicate at the earliest warning signs 1

Standard Dosing Algorithm

Initial loading dose:

  • 1.2 mg (two 0.6 mg tablets) immediately at flare onset 1, 2, 3, 4
  • Followed by 0.6 mg (one tablet) exactly one hour later 1, 2, 3, 4
  • Total loading dose: 1.8 mg over one hour 1, 2, 3

Continuation dosing:

  • Wait 12 hours after the loading doses 1, 2
  • Resume 0.6 mg once or twice daily until complete attack resolution 1, 2, 3
  • Maximum daily dose for prophylaxis: 1.2 mg/day 2, 3, 4

Dose Adjustments for Kidney Impairment

Mild to moderate renal impairment (eGFR 30-80 mL/min):

  • Use standard loading dose (1.2 mg followed by 0.6 mg one hour later) 2, 4
  • Monitor closely for adverse effects 2, 4
  • Treatment courses should not be repeated more than once every two weeks in severe impairment (eGFR <30 mL/min) 4

Severe renal impairment (eGFR <30 mL/min):

  • Strongly consider alternative therapy first (corticosteroids preferred) 1, 2
  • If colchicine must be used: single dose of 0.6 mg only 4
  • Do not repeat treatment for at least two weeks 4

Dialysis patients:

  • Single dose of 0.6 mg maximum 4
  • Do not repeat for at least two weeks 4

Absolute Contraindications

Do not use colchicine if the patient is taking: 1, 2, 4

  • Strong CYP3A4 inhibitors: clarithromycin, erythromycin, ketoconazole, itraconazole, ritonavir
  • P-glycoprotein inhibitors: cyclosporine, verapamil
  • This combination dramatically increases colchicine plasma levels and risk of fatal toxicity 1, 2

Additional contraindications:

  • Severe renal impairment (eGFR <30 mL/min) combined with any CYP3A4 or P-gp inhibitor use 1, 2
  • Patients with both renal AND hepatic impairment taking these interacting drugs 1

Alternative Treatment Options When Colchicine Cannot Be Used

First-line alternatives: 1, 2

  • NSAIDs at full FDA-approved doses (naproxen, indomethacin, sulindac) until complete resolution 1
  • Oral corticosteroids: prednisone 30-35 mg daily for 3-5 days, or 0.5 mg/kg/day for 5-10 days 1, 2
  • Intra-articular corticosteroid injection for monoarticular or oligoarticular involvement 1, 2

Evidence Quality and Rationale

  • The low-dose regimen (1.8 mg total) is supported by the AGREE trial, which demonstrated equal efficacy to high-dose colchicine (4.8 mg) with significantly fewer gastrointestinal side effects 1, 5, 6
  • Number needed to treat (NNT) is 5 for achieving ≥50% pain reduction at 24 hours 1
  • The older high-dose regimen (0.5 mg every 2 hours until relief or toxicity) is obsolete and causes severe diarrhea in most patients 1, 7

Common Pitfalls to Avoid

  • Never exceed 1.8 mg in the first hour—higher doses provide no additional benefit but substantially increase gastrointestinal toxicity 1, 5, 6
  • Do not use colchicine for delayed presentations (>36 hours after onset) 1, 2, 3
  • Always calculate eGFR before prescribing to identify patients requiring dose adjustment or alternative therapy 2
  • Screen for drug interactions with CYP3A4/P-gp inhibitors before prescribing 1, 2, 4
  • Avoid combining NSAIDs with systemic corticosteroids due to synergistic gastrointestinal toxicity 1

Special Consideration: Patients Already on Prophylactic Colchicine

  • If already taking prophylactic colchicine (0.6 mg once or twice daily) when a flare occurs, give the full loading dose (1.2 mg followed by 0.6 mg one hour later) 1, 4
  • Wait 12 hours after loading doses, then resume the regular prophylactic dose 1, 4

References

Guideline

Treatment of Acute Gout Flares

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colchicine Dosing Regimens for Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colchicine Dosage for Acute Gout and Prophylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Colchicine for the treatment of gout.

Expert opinion on pharmacotherapy, 2010

Research

Does colchicine work? The results of the first controlled study in acute gout.

Australian and New Zealand journal of medicine, 1987

Related Questions

What is the typical duration of colchicine (Colchicine) treatment for an acute gout flare?
What is the recommended dosage and treatment duration of colchicine for an adult patient with normal renal function experiencing a gout flare?
Can a patient undergoing chemotherapy take colchicine for gout?
What is the recommended dosage and management of colchicine for gout treatment?
What is the recommended dosing for colchicine (Colcrys) in patients with acute gout flare and impaired renal function?
What is the interpretation of Hepatitis B (HBV) lab results showing a reactive Hepatitis B surface antigen (HBsAg) and low Hepatitis B surface antibody (anti-HBs) initially, followed by normalization and evidence of immunity with a reactive anti-HBs and non-reactive HBsAg in a patient with a history of abnormal HBV labs?
What is the recommended evaluation and management for a patient with symptoms of urinary obstruction, including manual pressure under the testicles to fully empty the bladder and a weaker urine stream, who is asymptomatic otherwise but attributes the weaker stream to aging?
Is Strattera (atomoxetine) contraindicated in a patient with a history of anorexia nervosa and bulimia?
What do I do if I realize I've selected the wrong protocol during a procedure on a patient with impaired renal function?
What is the best treatment approach for a non-compliant patient with poorly controlled type 2 diabetes, indicated by a Hemoglobin A1c (Hgb A1c) level of 11%?
How to manage radiologic procedures in a patient with impaired renal function to minimize nephrotoxicity?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.